Evidence map›Paper›PMID 35903189›Full record

ReviewFrontiers in chemistry2022

Advances in Blue Exciplex-Based Organic Light-Emitting Materials and Devices.

Jie Li, Zhi Li, Hui Liu, Heqi Gong, Jincheng Zhang, Qiang Guo

Abstract readReview
In one paragraph

Review in Frontiers in chemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jie LiCollege of Optoelectronic Engineering, Chengdu University of Information Technology, Chengdu, China.
Zhi LiCollege of Optoelectronic Engineering, Chengdu University of Information Technology, Chengdu, China.
Hui LiuCollege of Optoelectronic Engineering, Chengdu University of Information Technology, Chengdu, China.
Heqi GongCollege of Optoelectronic Engineering, Chengdu University of Information Technology, Chengdu, China.
Jincheng ZhangCollege of Optoelectronic Engineering, Chengdu University of Information Technology, Chengdu, China.
Qiang GuoCollege of Optoelectronic Engineering, Chengdu University of Information Technology, Chengdu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Exciplexes possessing thermally activated delayed fluorescence (TADF) characteristics have received much attention in the fields of organic light-emitting materials and devices over the past decade. In general, an exciplex is a physical mixture between a donor (D) with hole transport properties and an acceptor (A) with electron transport characteristics, and the energy difference between the lowest excited singlet state and the lowest excited triplet state is usually fairly small in terms of the long-range charge-transfer process from D to A. In the processes of photoluminescence and electroluminescence, triplet excitons can be converted to singlet excitons through reverse intersystem crossing and then radiate photons to achieve TADF. As a consequence, triplet excitons can be effectively harvested, and the exciton utilization can be significantly enhanced. Up to now, a large number of exciplexes have been developed and applied to organic light-emitting devices. Notably most of them showed green or red emission, while blue exciplexes are relatively few owing to the spectrum characteristics of the large red-shift and broadened emission. In this study, the latest progress of blue exciplex-based organic light-emitting materials and devices is briefly reviewed, and future research is prospected.

Indexed as

blue exciplexcohostorganic light-emitting diodereverse intersystem crossingthermally activated delayed florescence

Identifiers

PMID35903189
PMCPMC9320026

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.